🔗 Permalink

Inventor profile of:

Daniel ELBAUM

City:

Newton, Massachusetts

Country:

United States

Published Applications:

Last publication date:

2024-05-16

Top Assignees for applications by Daniel ELBAUM

The entities that hold a legal rights for patent applications filed by inventor ELBAUM Daniel:

Ra Pharmaceuticals, Inc. 16 Cambridge, MA United States
Amgen Inc. 13 Thousand Oaks, CA United States
CORNERSTONE THERAPEUTICS INC. 4 Cary, NC United States
FoldRx Pharmaceuticals, Inc. 1 Cambridge, MA United States
RICHARD B. THOMPSON 1 Baltimore, MD United States
Cornerstone Therapeutic, Inc. 1 Cary, NC United States
Retrophin, Inc. 1 San Diego, CA United States
The Feinstein Institute For Medical Research 1 Manhasset, NY United States
VERTEX PHARMACEUTICALS INCORPORATED 1 Cambridge, MA United States

Recent patent applications by ELBAUM Daniel

Daniel ELBAUM from Newton, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2024-05-16

US20240156896A1

Human necessities

Modulators of complement activity

#2 | 2023-07-27

US20230235332A1

Chemistry; metallurgy

TREATMENT OF NEUROLOGICAL DISEASES USING MODULATORS OF GENE TRANSCRIPTS

#3 | 2022-12-27

US17724304

Chemistry; metallurgy

Modulation of complement activity

#4 | 2022-11-24

US20220372489A1

Chemistry; metallurgy

PPM1A INHIBITORS AND METHODS OF USING SAME

#5 | 2021-09-16

US20210283212A1

Human necessities

Modulators of complement activity

#6 | 2021-08-12

US20210246167A1

Chemistry; metallurgy

Modulation of complement activity

#7 | 2020-05-21

US20200155639A1

Human necessities

Modulators of complement activity

#8 | 2020-04-23

US20200123202A1

Chemistry; metallurgy

Modulation of complement activity

#9 | 2019-11-07

US20190337971A1

Chemistry; metallurgy

PANTETHEINE DERIVATIVES FOR THE TREATMENT OF NEUROLOGIC DISORDERS

#10 | 2019-10-10

US20190307835A1

Human necessities

Modulators of complement activity

#11 | 2019-04-25

US20190119328A1

Chemistry; metallurgy

Modulation of complement activity

#12 | 2018-12-27

US20180371019A1

Chemistry; metallurgy

Modulation of complement activity

#13 | 2018-12-20

US20180362564A1

Chemistry; metallurgy

Cyclic phosphates and cyclic phosphoramidates for the treatment of neurologic disorders

#14 | 2018-09-13

US20180256672A1

Human necessities

Peptide and peptidomimetic inhibitors

#15 | 2018-07-12

US20180193408A1

Human necessities

Modulators of complement activity

#16 | 2018-01-25

US20180021402A1

Human necessities

Modulators of complement activity

#17 | 2017-07-06

US20170189470A1

Human necessities

Peptide and peptidomimetic inhibitors

#18 | 2017-05-18

US20170137468A1

Chemistry; metallurgy

Modulation of complement activity

#19 | 2017-05-18

US20170136007A1

Human necessities

NOVEL PIPERAZINES, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF

#20 | 2016-03-24

US20160083430A1

Chemistry; metallurgy

Peptide and peptidomimetic inhibitors

#21 | 2015-06-18

US20150166606A1

Chemistry; metallurgy

Peptide and peptidomimetic inhibitors

#22 | 2014-11-20

US20140343059A1

Chemistry; metallurgy

Piperazines, pharmaceutical compositions and methods of use thereof

#23 | 2013-10-17

US20130273004A1

Chemistry; metallurgy

SUBSTITUTED ALKYLAMINE DERIVATIVES AND METHODS OF USE

#24 | 2012-03-22

US20120071652A1

Human necessities

Piperazines, pharmaceutical compositions and methods of use thereof

#25 | 2012-03-15

US20120065185A1

Chemistry; metallurgy

Substituted alkylamine derivatives and methods of use

#26 | 2011-08-02

US10671967

Inhibitors of IMPDH enzyme

#27 | 2010-12-30

US20100331297A1

Human necessities

MODULATION OF PROTEIN TRAFFICKING

#28 | 2010-12-09

US20100311773A1

Chemistry; metallurgy

Anabaseine derivatives, pharmaceutical compositions and methods of use thereof

#29 | 2009-05-12

US10804915

Heterocyclic compounds and methods of use

#30 | 2008-02-28

US20080051415A1

Human necessities

Piperazines, pharmaceutical compositions and methods of use thereof

#31 | 2007-10-04

US20070232651A1

Chemistry; metallurgy

Anabaseine derivatives, pharmaceutical compositions and method of use thereof

#32 | 2006-09-12

US10046622

Substituted amine derivatives and methods of use

#33 | 2006-09-05

US10823809

Substituted arylamine derivatives and methods of use

#34 | 2006-09-05

US10197918

Substituted amine derivatives and methods of use

#35 | 2006-08-31

US20060194848A1

Chemistry; metallurgy

Substituted amine derivatives and methods of use

#36 | 2006-07-11

US10699518

Kinase inhibitors

#37 | 2006-02-23

US20060040956A1

Chemistry; metallurgy

Substituted pyridinecarboxamides for the treatment of cancer

#38 | 2006-02-07

US10046681

Substituted alkylamine derivatives and methods of use

#39 | 2005-11-24

US20050261313A1

Chemistry; metallurgy

Process for preparing 3,3-dimethylindolines

#40 | 2005-11-10

US20050250170A1

Physics

Determination of metal ions in solution by photoluminescence anisotropy

#41 | 2005-07-14

US20050153960A1

Chemistry; metallurgy

Substituted arylamine derivatives and methods of use

#42 | 2005-05-19

US20050107374A1

Chemistry; metallurgy

Substituted heterocyclic compounds and methods of use

#43 | 2005-04-12

US10197974

Substituted alkylamine derivatives and methods of use

#44 | 2005-03-10

US20050054670A1

Chemistry; metallurgy

Substituted 2,3-dihydro-1h-isoindol-1-one derivatives and methods of use

#45 | 2005-02-03

US20050026914A1

Chemistry; metallurgy

Substituted heterocyclic compounds and methods of use

InventorID:

486111 ⎘